Sonic Healthcare (SHL.AX) Stock Price
Sonic Healthcare Price
Revenue has compounded at 9.8% per year over the past 19 years to 10.95 B AUD. Earnings per share have grown at 3.9% per year over the last 19 years. Sonic Healthcare's net margin stands at 5.6%, down from 15.7% several years earlier. Sonic Healthcare currently offers a dividend yield of about 6.98%. The payout ratio is around 105% of earnings. The dividend has grown at 3.6% per year over the past 19 years. Analysts set a median price target of 25.47 AUD, implying 37.8% above the current price. Of 18 analysts, 8 rate the stock a buy — an overall Hold consensus.
Sonic Healthcare stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Sonic Healthcare business model & stock analysis
Frequently asked questions about Sonic Healthcare
The business model of Sonic Healthcare Ltd revolves around providing comprehensive and high-quality medical diagnostic services. As one of the largest global pathology providers, Sonic Healthcare operates an extensive network of laboratories and healthcare facilities worldwide. The company offers an array of diagnostic tests, including pathology, radiology, molecular diagnostics, and laboratory management services. Sonic Healthcare's business model focuses on delivering accurate and timely results, enabling enhanced patient care and treatment decisions. By leveraging advanced technology and a dedicated team of healthcare professionals, Sonic Healthcare aims to improve patient outcomes and contribute to the overall advancement of healthcare services globally.
Sonic Healthcare Ltd is primarily active in the healthcare industry.
The main competitors of Sonic Healthcare Ltd in the market are LabCorp, Quest Diagnostics, and Becton, Dickinson and Company (BD).
Sonic Healthcare Ltd is a leading global medical diagnostics company. Established in 1987, Sonic Healthcare has grown to become one of the largest pathology providers worldwide. The company is headquartered in Sydney, Australia, and operates in more than 30 countries, including the United States, Germany, and the United Kingdom. Sonic Healthcare offers a comprehensive range of laboratory and radiology services, catering to both the private and public healthcare sectors. With a strong focus on innovation and technological advancements, Sonic Healthcare continues to provide accurate and timely diagnostic solutions for patient care.
Sonic Healthcare Ltd has achieved significant milestones throughout its history. The company, which is a leading provider of laboratory and diagnostic services globally, has consistently expanded its operations and enhanced its offerings. With a strong focus on innovation and technology, Sonic Healthcare has successfully implemented advanced diagnostic techniques and state-of-the-art laboratory equipment. Additionally, the company has established strategic partnerships and acquisitions, further strengthening its market position. Sonic Healthcare's commitment to delivering high-quality healthcare services has earned it recognition and trust from patients and medical professionals worldwide. Through continuous growth and advancements, Sonic Healthcare Ltd has solidified its reputation as a premier provider in the field of healthcare diagnostics.
Sonic Healthcare Ltd is primarily present in various countries and regions around the world. With operations in Australia, the United States, Germany, the United Kingdom, Switzerland, Belgium, New Zealand, and Ireland, Sonic Healthcare has established a global presence in the healthcare industry. Through its extensive network of clinical laboratories and diagnostic services, the company serves patients and healthcare providers in these locations, delivering high-quality healthcare solutions. Sonic Healthcare Ltd's widespread international presence allows it to leverage its expertise and resources across different markets, contributing to its success as a leading provider of laboratory medicine and pathology services.
Sonic Healthcare Ltd represents values of excellence, integrity, and innovation in the healthcare industry. As a leading global provider of diagnostic services, Sonic Healthcare is committed to delivering the highest quality of patient care and accurate medical testing. The company's corporate philosophy revolves around maintaining strong relationships with healthcare professionals, investing in advanced technologies, and continuously improving healthcare outcomes. Sonic Healthcare's dedication to accuracy, reliability, and ethical practices has positioned it as a trusted partner for healthcare organizations worldwide. With a focus on superior patient care and continuous advancement, Sonic Healthcare Ltd remains at the forefront of the healthcare sector.
Analysts currently set an average price target of 26.14 AUD for the Sonic Healthcare stock (median: 25.47 AUD), implying +41.4 % versus the latest price. The consensus is based on 18 analyst ratings.
18 analysts currently rate the Sonic Healthcare stock: 8 recommend buying, 8 holding and 2 selling.
Converted at the current exchange rate, the Sonic Healthcare share trades at 11.54 EUR (18.49 AUD).
The Sonic Healthcare share (SHL.AX) is listed on 7 stock exchanges, including: SIX (Zürich) (SHL1.SW), ASX (SHL.AX), Frankfurt (SAB.F), München (SAB.MU), Düsseldorf (SAB.DU), Hamburg (SAB.HM).
Sonic Healthcare Ltd is an Australian company that offers laboratory services in various healthcare industries. The company currently operates over 270 labs in 8 countries, including Australia, Europe, Asia, and North America. The company provides a wide range of laboratory services, including diagnostic tests, pathology, oncology, reproductive health, as well as forensic and environmental testing. Sonic also operates medical centers and hospitals and offers telemedicine services. With a strong presence in Australia and Europe, Sonic Healthcare Ltd is the largest medical diagnostics company in Australia and the third largest in Europe. The company also offers its services in North America, where Sonic Healthcare Ltd is represented in over 20 states. Sonic Healthcare Ltd aims to provide top-quality, cost-effective healthcare services by utilizing innovative technologies and state-of-the-art diagnostic techniques. The company has invested in new technologies, such as artificial intelligence, in recent years to improve the efficiency and accuracy of its diagnostic tests. Sonic Healthcare Ltd also offers specialized services in the fields of oncology and reproductive health. These include genetic testing, prostate cancer diagnostics, breast cancer screening, and fertility testing. The company works closely with medical professionals to offer these patients specialized and personalized services. In 2020, the company achieved a revenue of 7.8 billion AUD and employed 36,000 employees. Sonic Healthcare Ltd has a highly diversified customer base and collaborates with various healthcare facilities, private hospitals, and public health authorities. With a strong global presence and its laboratory services in various healthcare sectors, Sonic Healthcare Ltd is well-positioned. The company aims to provide top-quality, cost-effective services and to utilize the latest technologies and diagnostic techniques to improve performance. In a market characterized by consolidation and high competitive pressure, Sonic Healthcare Ltd will continue to grow and focus on innovative technologies and customer-oriented services to maintain its position as one of the leading providers of laboratory services in the healthcare industry.
The revenue of Sonic Healthcare is 10.95 B AUD. This figure is based on current financial data and reflects the company's business performance.
The profit of Sonic Healthcare is 608.29 M AUD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Sonic Healthcare is currently 15.04. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Sonic Healthcare stock.
The price-to-sales ratio (P/S) of Sonic Healthcare is currently 0.84. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Sonic Healthcare stock.
The Eulerpool Quality Score for Sonic Healthcare is 6/10.
The ISIN of Sonic Healthcare is AU000000SHL7. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Sonic Healthcare is 909081. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Sonic Healthcare is SHL.AX. The ticker symbol is used to trade Sonic Healthcare shares on the stock exchange.
Sonic Healthcare stock
Sonic Healthcare Peer Group
Sonic Healthcare Ticker
Sonic Healthcare FIGI
All fundamentals and in-depth analysis of Sonic Healthcare
Our stock analysis for Sonic Healthcare stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Sonic Healthcare. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.